ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Aripiprazole in Children and Adolescents With Bipolar I Disorder

ClinicalTrials.gov ID: NCT00110461

Public ClinicalTrials.gov record NCT00110461. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Trial to Test the Safety and Efficacy of Two Doses of Aripiprazole in Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features

Study identification

NCT ID
NCT00110461
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
296 participants

Conditions and interventions

Interventions

  • Aripiprazole Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
10 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2005
Primary completion
Jan 31, 2007
Completion
Jan 31, 2007
Last update posted
May 20, 2012

2005 – 2007

United States locations

U.S. sites
53
U.S. states
26
U.S. cities
53
Facility City State ZIP Site status
Local Institution Scottsdale Arizona
Local Institution Little Rock Arkansas
Local Institution National City California
Local Institution Orange California
Local Institution Pasadena California
Local Institution Sacramento California
Local Institution San Diego California
Local Institution Stanford California
Local Institution Washington D.C. District of Columbia
Local Institution Altamonte Springs Florida
Local Institution Hialeah Florida
Local Institution Jacksonville Florida
Local Institution Miami Florida
Local Institution North Miami Florida
Local Institution Tampa Florida
Local Institution Atlanta Georgia
Local Institution Smyrna Georgia
Local Institution Boise Idaho
Local Institution Chicago Illinois
Local Institution Libertyville Illinois
Local Institution Indianapolis Indiana
Local Institution Kansas City Kansas
Local Institution Newton Kansas
Local Institution Lexington Kentucky
Local Institution Baton Rouge Louisiana
Local Institution Lake Charles Louisiana
Local Institution Shreveport Louisiana
Local Institution Cambridge Massachusetts
Local Institution Medford Massachusetts
Local Institution Clinton Township Michigan
Local Institution Rochester Hills Michigan
Local Institution Kansas City Missouri
Local Institution St Louis Missouri
Local Institution Las Vegas Nevada
Local Institution Elmsford New York
Local Institution New York New York
Local Institution Rochester New York
Local Institution Stony Brook New York
Local Institution Cincinnati Ohio
Local Institution Cleveland Ohio
Local Institution Oklahoma City Oklahoma
Local Institution Philadelphia Pennsylvania
Local Institution Charleston South Carolina
Local Institution Memphis Tennessee
Local Institution Bellaire Texas
Local Institution Fort Worth Texas
Local Institution Houston Texas
Local Institution San Antonio Texas
Local Institution Herndon Virginia
Local Institution Richmond Virginia
Local Institution Kirkland Washington
Local Institution Spokane Washington
Local Institution Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00110461, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 20, 2012 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00110461 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →